Benzinga | Dec 2, 2021 07:35AM EST

Xilio Therapeutics Q3 EPS $(21.27) Up From $(24.19) YoY

Xilio Therapeutics (NASDAQ:XLO) reported quarterly losses of $(21.27) per share. This is a 12.07 percent increase over losses of $(24.19) per share from the same period last year.